Coronary Artery Disease and Myocardial Infarction

Articles

Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease

Citation:

US Cardiology Review 2017;11(1):16–7

Guest Editorial: Commentary on the Findings of the GLAGOV Randomized Clinical Trial

Citation:

US Cardiology Review 2017;11(1):18–9

Key Recent Advances in Atherosclerosis Treatment with Modern Lipid-lowering Drugs: The New Frontier with PCSK9 Inhibitors

Citation:

European Cardiology Review 2017;12(1):30–2

Direct Oral Anticoagulants: A Quick Guide

Citation:

European Cardiology Review 2017;12(1):40–5.